Results 31 to 40 of about 67,580 (201)

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). [PDF]

, 2016
This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) [Grant 5 x mille n.9980, (to M.F., F.M. and A. N.)]; AIRC I.G. [n. 14,326 (to M.F.)], [n.10136 and 16,722 (A.N.)], [n.15426 (to F.F.)].
Baio, Gabriella, Basso, Luca, Boccardo, Simona, Calabrese, Massimo, Castronovo, Angela, Cilli, Michele, Cutrona, Giovanna, Emionite, Laura, Fais, Franco, Ferrarini, Manlio, Gentile, Massimo, Massucco, Carlotta, Matis, Serena, Morabito, Fortunato, Neri, Antonino, Neumaier, Carlo Emanuele, Pace, Daniele, Ravina, Marco, Recchia, Anna Grazia, Rosa, Francesca, Salvi, Sandra, Truini, Mauro, Valdora, Francesca   +22 more
core   +2 more sources

ONCOLOGIA – DESFECHOS E EXPERIÊNCIA DA COMISSÃO NACIONAL DE INCORPORAÇÃO DE TECNOLOGIAS NO SISTEMA ÚNICO DE SAÚDE

Revista Gestão & Saúde, 2015
Em todo o mundo, há dificuldade na avaliação de tecnologias em saúde (ATS) aplicadas à oncologia. Os autores descrevem a recente experiência da Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC) na área de oncologia, fornecendo elementos ...
Maria Pordeus Gadelha, Sandro José Martins, Clarice Alegre Petramale   +2 more
doaj   +1 more source

Symptomatic Vulvar Primary Cutaneous Amyloidosis Associated With Low-Risk HPV: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Primary localized cutaneous amyloidosis (PCLA) of the vulva is an infrequent diagnosis. Its clinical presentation may mimic neoplastic or inflammatory lesions and could even be associated with human papillomavirus (HPV) of low or high oncogenic risk, making accurate diagnosis and exclusion of systemic involvement essential. A 73‐year‐old woman
Hoegl J, Fernandes A, Marquez D, Silva Y.   +3 more
europepmc   +2 more sources

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer [PDF]

, 2010
Objectives: Bevacizumab is a monoclonal antibody that directly inhibits vascular endothelial growth factor, a key regulator of angiogenesis. Bevacizumab significantly improves progression-free and/or overall survival in metastatic colorectal cancer in ...
Heinemann, Volker, Hoff, Paulo M.
core   +1 more source

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study [PDF]

, 2017
Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate approved for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive, metastatic breast cancer (mBC).
Alesini, Daniele, Arpino, Grazia, Cannita, Katia, Carbognin, Luisa, Caruso, Michele, Cianniello, Daniela, Ciccarese, Mariangela, Cognetti, Francesco, D\u2019Ottavio, Anna Maria, De Laurentiis, Michelino, Fabbri, Agnese, Fabi, Alessandra, Filippelli, Gianfranco, Generali, Daniele, Giampaglia, Marianna, Giannarelli, Diana, La Verde, Nicla, Leonardi, Vita, Montemurro, Filippo, Moscetti, Luca, Paris, Ida, Rossello, Rosalba, Russillo, Michelangelo, Santini, Daniele, Scandurra, Giuseppa, Stani, Simonetta, Valle, Enrichetta, Zambelli, Alberto   +27 more
core   +1 more source

A Mussel‐Inspired Bioadhesive Patch to Selectively Kill Glioblastoma Cells

Advanced Science, EarlyView.
An innovative mussel‐inspired bioadhesive patch has been developed for post‐surgical glioblastoma treatment. The patch, which adheres strongly in biological environments, releases a localized treatment. This treatment, acting via reactive oxygen species, shows specific toxicity to glioblastoma cells.
Jose Bolaños‐Cardet, Sara Pugliese, Jordi Bruna, Daniel Ruiz‐Molina, Salvio Suárez‐García, Victor J. Yuste   +5 more
wiley   +1 more source

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
External comparator cohort (ECC) studies with real‐world data (RWD) may provide more reliable estimates of treatment differences compared to single‐arm trials (SAT), yet they face limitations such as selection bias and data heterogeneity. This study assessed the perceived strength of evidence of ECC studies compared to SAT and randomized controlled ...
Francesco Pignatti, Tarec Christoffer El‐Galaly, Martin Kaiser, Kimmo Porkka, Robin Doeswijk, Peter Mol, Donna R. Rivera, Catherine C. Lerro, Ulrich‐Peter Rohr, Patrice Verpillat, Antonios Valachis, Dario Trapani, Massimo Di Maio, Nicola Latino, Raul Cordoba, Nathan Cherny, Miriam Koopman, Diogo Martins‐Branco, George Pentheroudakis, Douwe Postmus   +19 more
wiley   +1 more source

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

Cancer Management and Research, 2021
Agustín Falco,1 Thiago Bueno de Oliveira,2 Jon Cacicedo,3 Aylen Vanessa Ospina,4 Miguel Ángel Ticona,5 Héctor Galindo,6 Marcos David Pereira,7 José Luis Aguilar-Ponce,8 Antonio Rueda-Domínguez,9 Tannia Soria,10 Miren Taberna,11 Lara Iglesias,12 Taysser ...
Falco A, de Oliveira TB, Cacicedo J, Ospina AV, Ticona MÁ, Galindo H, Pereira MD, Aguilar-Ponce JL, Rueda-Domínguez A, Soria T, Taberna M, Iglesias L, Sowley T, Mesía R   +13 more
doaj  

TROMBOSE DE SÍTIO ATÍPICO EM PACIENTE COM HEMOGLOBINÚRIA PAROXÍSTICA NOTURNA

Hematology, Transfusion and Cell Therapy, 2023
Objetivo: Descrever caso de paciente com Hemoglobinúria Paroxística Noturna (HPN) com apresentação de trombose em sítio atípico e o manejo do mesmo.
MHS Duraes, RMMS Soares, CC Sartorio, DN Cysne, RFP Mendes, GC Pereira, DET Silva, JAS Abdon, FD Xavier, FSB Ferreira   +9 more
doaj   +1 more source

Comparative evaluation of prophylactic strategies for postpartum hemorrhage in vaginal delivery

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare the efficacy of different prophylactic oxytocin regimens in preventing postpartum hemorrhage (PPH) after vaginal delivery. Methods Single‐center retrospective cohort study including all vaginal deliveries between February 1, 2022, and December 31, 2023, at a tertiary referral unit.
Stefania Fieni, Giovanni Morganelli, Alissa Valenti, Debora Formisano, Gabriella Maria Celora, Biancamaria Mastrandrea, Tullio Ghi   +6 more
wiley   +1 more source